- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Praluent
Total 47 results
-
University of SalernoNot yet recruitingCardiovascular Diseases | Dyslipidemias | Lipid Metabolism Disorders | Statin Adverse Reaction
-
Sun U. KwonNot yet recruitingStroke, Acute Ischemic | PCSK9 InhibitorKorea, Republic of
-
Jonathan SevranskyRegeneron PharmaceuticalsRecruiting
-
Federico II UniversityRecruitingHypercholesterolemiaItaly
-
Second Xiangya Hospital of Central South UniversityNot yet recruiting
-
Chang Gung Memorial HospitalChang Gung UniversityRecruitingAcute Ischemic Stroke | Intracranial Atherosclerosis | ICAS - Intracranial AtherosclerosisTaiwan
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); BiovaloremActive, not recruitingPancreatic Cancer | Metastatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreas CancerCanada
-
GWT-TUD GmbHActive, not recruitingDyslipoproteinemiasGermany
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitation
-
University of VirginiaNorthwestern UniversityCompletedPeripheral Arterial DiseaseUnited States
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaCzechia, France, Denmark, Netherlands, Austria, Mexico, Spain, United States, Argentina, Brazil, Bulgaria, Canada, Finland, Hungary, Italy, Lebanon, Norway, Poland, Russian Federation, Slovenia, South Africa, Sweden, Taiwan, Turkey
-
LIB Therapeutics LLCCompletedCardiovascular Diseases | HypercholesterolemiaUnited States
-
SanofiCompletedAtherosclerotic Cardiovascular Disease | Primary Hypercholesterolaemia and Mixed DyslipidaemiaGermany
-
Gloria VegaRegeneron Pharmaceuticals; Aventis PharmaceuticalsTerminatedNephrotic SyndromeUnited States
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaFrance, Belgium, Austria, Canada, Czechia, Denmark, Finland, Germany, Greece, Hungary, Poland, Romania, Slovakia, Slovenia, Spain, Switzerland
-
Minneapolis Heart Institute FoundationRegeneron PharmaceuticalsTerminatedSaphenous Vein Graft AtherosclerosisUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeActive, not recruitingCardiovascular Diseases | AtherosclerosisUnited Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedHomozygous Familial HypercholesterolemiaUnited States, South Africa, Canada, Greece, Japan, Ukraine, Austria, Czechia, France, Germany, Italy, Taiwan, Turkey
-
Regeneron PharmaceuticalsSanofiTerminatedHeterozygous Familial Hypercholesterolemia | Non-familial HypercholesterolemiaUnited States, Bulgaria, Estonia, Russian Federation, South Africa, Ukraine
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaUnited States, Bulgaria, Chile, Estonia, Japan, Mexico, Russian Federation, South Africa, Ukraine
-
Regeneron PharmaceuticalsSanofiTerminatedHypercholesterolemiaUnited States
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemia | Heterozygous Familial HypercholesterolemiaUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaFrance, United States
-
Regeneron PharmaceuticalsSanofiCompletedHeterozygous Familial HypercholesterolemiaUnited States, Germany
-
University of UtahRegeneron PharmaceuticalsTerminatedStroke | Intracranial Atherosclerosis | Intraplaque HemorrhageUnited States
-
Baylor Research InstituteRegeneron PharmaceuticalsUnknownHemodialysis | Peritoneal Dialysis | Hypercholesterolemia | Atherosclerotic DiseaseUnited States
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemia | Acute Coronary SyndromeJapan
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNorway, Russian Federation, Sweden, South Africa, Czechia, United States, Canada, France, Netherlands, Spain
-
Virginia Commonwealth UniversitySanofi; Regeneron PharmaceuticalsCompletedMyocardial Infarction | HypercholesterolemiaUnited States
-
Imperial College LondonRegeneron Pharmaceuticals; Baim Institute for Clinical ResearchWithdrawnMyocardial Infarction | DyslipidemiasUnited Kingdom
-
Westside Medical Associates of Los AngelesRegeneron Pharmaceuticals; University of WashingtonUnknownAtherosclerosis | HyperlipidemiaUnited States
-
SanofiRegeneron PharmaceuticalsCompletedAtherosclerotic Cardiovascular DiseaseChina, Hong Kong, Austria, Bulgaria, Norway, Peru, France, Japan, Spain, Lithuania, Philippines, Israel, Belgium, Croatia, Poland, Hungary, Chile, Mexico, Latvia, Singapore, Switzerland, Colombia, Greece, Ukraine, Turkey, Finland, United States and more
-
Washington University School of MedicineCompleted
-
Kobe UniversityUnknown
-
Wolfson Medical CenterSanofi; Assaf-Harofeh Medical CenterUnknown
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Australia, Belgium, Canada, Denmark, Netherlands, New Zealand, Spain
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Argentina, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Mexico, Netherlands, Norway, Portugal, Romania, Russian Federation, South Africa, Spain, Sweden, United...
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaBelgium, Spain, Germany, Austria, Italy, United States, France, Netherlands, Switzerland, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedDyslipidemiaUnited States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaKorea, Republic of, Taiwan
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaUnited States, Bulgaria, Canada, Norway, Israel, Slovakia, United Kingdom, Hungary
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNetherlands, United States, Canada, Russian Federation, South Africa
-
SanofiRegeneron PharmaceuticalsCompleted
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Canada, Denmark, France, Hungary, Israel, Korea, Republic of, Russian Federation, South Africa, Ukraine
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Austria, Canada, Czech Republic, Denmark, France, Israel, Netherlands, Norway, Russian Federation, South Africa, Spain, Sweden, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaSweden, Germany, Russian Federation, Denmark, Israel, South Africa, Spain, Hungary, United States, Colombia, Czech Republic, Argentina, Belgium, Bulgaria, Canada, Chile, Finland, France, Italy, Mexico, Netherlands, Norway, Poland, Por... and more